The Artificial Intelligence In Cardiology Market is Predict to reach USD 18.21 Billion by 2032, at a CAGR of 32.3%

Artificial Intelligence In Cardiology Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Artificial Intelligence In Cardiology Market size is expected to reach $18.21 billion by 2032, rising at a market growth of 32.3% CAGR during the forecast period.

The integration of AI with telemedicine platforms is another significant trend, enhancing remote care capabilities. AI-powered telemedicine solutions ensure continuous patient engagement, particularly for managing chronic conditions like hypertension and heart failure. Additionally, there is a growing emphasis on collaborative innovation, with partnerships between technology companies, research institutions, and healthcare providers driving the development of AI solutions.

The Hardware segment is experiencing a CAGR of 31.6 % during the forecast period. Hardware plays a foundational role in the market, serving as the physical infrastructure that powers data processing, algorithmic computations, and real-time analytics critical to cardiovascular diagnostics and treatment. In cardiology, AI applications such as echocardiography image analysis, electrocardiogram (ECG) interpretation, and predictive modeling for cardiac events require substantial computational power and efficient data handling—functions enabled by specialized hardware.

The Diagnosis segment led the maximum revenue in the Global Artificial Intelligence In Cardiology Market by Application in 2024, thereby, achieving a market value of $7.03 billion by 2032. The application of Artificial Intelligence (AI) in cardiology diagnosis has become a transformative force in modern healthcare. Diagnosis represents one of the most impactful areas where AI is used in cardiology, assisting clinicians in identifying cardiovascular conditions such as arrhythmias, heart failure, coronary artery disease, and structural abnormalities.

The Ischemic Heart Disease /CAD segment is growing at a CAGR of 31.6 % during the forecast period. Ischemic Heart Disease (IHD), also referred to as Coronary Artery Disease (CAD), is a leading cause of morbidity and mortality globally. It arises when the coronary arteries, responsible for supplying oxygen-rich blood to the heart muscle, become narrowed or blocked due to atherosclerosis. In the context of the Artificial Intelligence (AI) in Cardiology Market, CAD has become a prime focus area for innovation.

Full Report: https://www.kbvresearch.com/artificial-intelligence-in-cardiology-market/

The North America region dominated the Global Artificial Intelligence In Cardiology Market by Region in 2024, thereby, achieving a market value of $7.56 billion by 2032. The Europe region is anticipated to grow a CAGR of 32% during (2025 - 2032). Additionally, The Asia Pacific region would witness a CAGR of 33.1% during (2025 - 2032).

List of Key Companies Profiled

• IDOVEN S.L.
• Ultromics Ltd.
• CardiAI.Inc.
• Tempus AI, Inc.
• Koninklijke Philips N.V.
• Cleerly, Inc.
• Vista AI, Inc.
• Viz.ai, Inc.
• RSIP Vision Ltd.
• GE HealthCare Technologies, Inc.

Artificial Intelligence In Cardiology Market Report Segmentation

By Component

• Hardware
• Software
• Services

By Application

• Diagnosis
• Prediction
• Drug Discovery
• Other Application

By Medical Condition

• Ischemic Heart Disease /CAD
• Cardiac Arrhythmias
• Heart Failure
• Other Medical Condition

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports: